Could a simple sugar alcohol prevent delirium after a heart attack?

NCT ID NCT06759259

Completed Prevention Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving mannitol, a substance that reduces brain swelling, could prevent delirium in older adults hospitalized for a heart attack. Fifty patients aged 65 and older with high inflammation levels were included. The goal was to see if mannitol could lower the chance of developing confusion and other delirium symptoms during their hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mannitol
What this could lead to: If it works, this could point toward a simple, low-cost way to prevent delirium in older heart attack patients.
What could go wrong: This is a very small, single-center study with only 50 participants. Results may not apply to all patients, and the effect may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM, INTENSIVE CARE UNIT, RANDOMISED CONTROLLED TRIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation myocardial infarction delirium prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM, INTENSIVE CARE UNIT, RANDOMISED CONTROLLED TRIAL MYOCARDIAL INFARCTION (MI)

Contacts and locations

Locations

Cardiology Reserch Institute Tomsk National Research Centre

Tomsk, Tomsk Oblast, 634012, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.